{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:03:34Z","timestamp":1782950614435,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373826"],"award-info":[{"award-number":["82373826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09891-6","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:35:27Z","timestamp":1774020927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An endoplasmic reticulum membrane-mimetic GPC3 mRNA nanovaccine for specific immunotherapy of hepatocellular carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Tian","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runshu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1763-9747","authenticated-orcid":false,"given":"Cong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyi","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-973X","authenticated-orcid":false,"given":"Haitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5139-9387","authenticated-orcid":false,"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2076-6228","authenticated-orcid":false,"given":"Cui-Yun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"9891_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1126\/science.adw0397","volume":"388","author":"X Gao","year":"2025","unstructured":"Gao, X. Empower the age of smart mRNA medicine: programmable RNA sensor and molecular tools refine therapeutic payload production. Science 388, 40\u201341 (2025).","journal-title":"Science"},{"key":"9891_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","volume":"21","author":"EJ Sayour","year":"2024","unstructured":"Sayour, E. J., Boczkowski, D., Mitchell, D. A. & Nair, S. K. Cancer mRNA vaccines: clinical advances and future opportunities. Nat. Rev. Clin. Oncol. 21, 489\u2013500 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9891_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","volume":"25","author":"CY Moon","year":"2025","unstructured":"Moon, C. Y. et al. Dendritic cell maturation in cancer. Nat. Rev. Cancer 25, 225\u2013248 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"9891_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","volume":"25","author":"C Luri-Rey","year":"2025","unstructured":"Luri-Rey, C. et al. Cross-priming in cancer immunology and immunotherapy. Nat. Rev. Cancer 25, 249\u2013273 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"9891_CR5","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. STING agonist-based ER-targeting molecules boost antigen cross-presentation. Nature. https:\/\/doi.org\/10.1038\/s41586-025-08758-w (2025).","DOI":"10.1038\/s41586-025-08758-w"},{"key":"9891_CR6","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41565-023-01453-9","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy. Nat. Nanotechnol. 18, 1364\u20131374 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"9891_CR7","doi-asserted-by":"publisher","unstructured":"Liu, C. et al. mRNA-based cancer therapeutics. Nat. Rev. Cancer. https:\/\/doi.org\/10.1038\/s41568-023-00586-2 (2023).","DOI":"10.1038\/s41568-023-00586-2"},{"key":"9891_CR8","doi-asserted-by":"publisher","unstructured":"Zong, Y., Lin, Y., Wei, T. & Cheng, Q. Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv. Mater. e2303261. https:\/\/doi.org\/10.1002\/adma.202303261 (2023).","DOI":"10.1002\/adma.202303261"},{"key":"9891_CR9","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov, R., Bird, R., Curtze, A. E. & Zhou, Q. Lipid nanoparticles horizontal line from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15, 16982\u201317015 (2021).","journal-title":"ACS Nano"},{"key":"9891_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202688","volume":"12","author":"W Yang","year":"2023","unstructured":"Yang, W., Mixich, L., Boonstra, E. & Cabral, H. Polymer-based mRNA delivery strategies for advanced therapies. Adv. Healthc. Mater. 12, e2202688 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"9891_CR11","doi-asserted-by":"publisher","unstructured":"Guo, X. et al. A Polymeric mRNA vaccine featuring enhanced site-specific mRNA delivery and inherent STING-stimulating performance for tumor immunotherapy. Adv. Mater. e2410998. https:\/\/doi.org\/10.1002\/adma.202410998 (2025).","DOI":"10.1002\/adma.202410998"},{"key":"9891_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114857","volume":"198","author":"B Wan","year":"2023","unstructured":"Wan, B., Bao, Q. & Burgess, D. Long-acting PLGA microspheres: Advances in excipient and product analysis toward improved product understanding. Adv. Drug Deliv. Rev. 198, 114857 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9891_CR13","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1016\/j.biomaterials.2011.01.067","volume":"32","author":"Z Zhang","year":"2011","unstructured":"Zhang, Z. et al. Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials 32, 3666\u20133678 (2011).","journal-title":"Biomaterials"},{"key":"9891_CR14","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. Versatile PLGA-based drug delivery systems for tumor immunotherapy. Small Methods, e2401623, https:\/\/doi.org\/10.1002\/smtd.202401623 (2025).","DOI":"10.1002\/smtd.202401623"},{"key":"9891_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4750","volume":"351","author":"MM Pakulska","year":"2016","unstructured":"Pakulska, M. M., Miersch, S. & Shoichet, M. S. Designer protein delivery: From natural to engineered affinity-controlled release systems. Science 351, aac4750 (2016).","journal-title":"Science"},{"key":"9891_CR16","doi-asserted-by":"publisher","unstructured":"Harguindey, A. et al. Synthesis and assembly of click-nucleic-acid-containing PEG-PLGA nanoparticles for DNA delivery. Adv Mater 29, https:\/\/doi.org\/10.1002\/adma.201700743 (2017).","DOI":"10.1002\/adma.201700743"},{"key":"9891_CR17","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1039\/C8TB00967H","volume":"6","author":"T Bus","year":"2018","unstructured":"Bus, T., Traeger, A. & Schubert, U. S. The great escape: how cationic polyplexes overcome the endosomal barrier. J. Mater. Chem. B 6, 6904\u20136918 (2018).","journal-title":"J. Mater. Chem. B"},{"key":"9891_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1021\/acsnano.8b05151","volume":"13","author":"M Wojnilowicz","year":"2019","unstructured":"Wojnilowicz, M., Glab, A., Bertucci, A., Caruso, F. & Cavalieri, F. Super-resolution imaging of proton sponge-triggered rupture of endosomes and cytosolic release of small interfering RNA. ACS Nano 13, 187\u2013202 (2019).","journal-title":"ACS Nano"},{"key":"9891_CR19","doi-asserted-by":"publisher","first-page":"e2209624","DOI":"10.1002\/adma.202209624","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam, K. et al. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications. Adv. Mater. 35, e2209624 (2023).","journal-title":"Adv. Mater."},{"key":"9891_CR20","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/adma.201505822","volume":"28","author":"OS Fenton","year":"2016","unstructured":"Fenton, O. S. et al. Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery. Adv. Mater. 28, 2939\u20132943 (2016).","journal-title":"Adv. Mater."},{"key":"9891_CR21","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1016\/j.biomaterials.2013.06.064","volume":"34","author":"H Li","year":"2013","unstructured":"Li, H. et al. Endoplasmic reticulum localization of poly(omega-aminohexyl methacrylamide)s conjugated with (L-)-arginines in plasmid DNA delivery. B. iomaterials 34, 7923\u20137938 (2013).","journal-title":"iomaterials"},{"key":"9891_CR22","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1021\/mp200583d","volume":"9","author":"MJ Reilly","year":"2012","unstructured":"Reilly, M. J., Larsen, J. D. & Sullivan, M. O. Polyplexes traffic through caveolae to the Golgi and endoplasmic reticulum en route to the nucleus. Mol. Pharm. 9, 1280\u20131290 (2012).","journal-title":"Mol. Pharm."},{"key":"9891_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10562-w","volume":"10","author":"C Qiu","year":"2019","unstructured":"Qiu, C. et al. Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes. Nat. Commun. 10, 2702 (2019).","journal-title":"Nat. Commun."},{"key":"9891_CR24","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1074\/jbc.271.12.6651","volume":"271","author":"X Buton","year":"1996","unstructured":"Buton, X., Morrot, G., Fellmann, P. & Seigneuret, M. Ultrafast glycerophospholipid-selective transbilayer motion mediated by a protein in the endoplasmic reticulum membrane.  J. Biol. Chem. 271, 6651\u20136657 (1996).","journal-title":"J. Biol. Chem."},{"key":"9891_CR25","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1091\/mbc.e03-06-0437","volume":"14","author":"S Puri","year":"2003","unstructured":"Puri, S. & Linstedt, A. D. Capacity of the golgi apparatus for biogenesis from the endoplasmic reticulum. Mol. Biol. Cell 14, 5011\u20135018 (2003).","journal-title":"Mol. Biol. Cell"},{"key":"9891_CR26","doi-asserted-by":"publisher","first-page":"10521","DOI":"10.1021\/acsnano.3c01446","volume":"17","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Breaking spatiotemporal barriers of immunogenic chemotherapy via an endoplasmic reticulum membrane-assisted liposomal drug delivery. ACS Nano 17, 10521\u201310534 (2023).","journal-title":"ACS Nano"},{"key":"9891_CR27","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","volume":"23","author":"CL Lorentzen","year":"2022","unstructured":"Lorentzen, C. L., Haanen, J. B., Met, O. & Svane, I. M. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Lancet Oncol. 23, e450\u2013e458 (2022).","journal-title":"Lancet Oncol."},{"key":"9891_CR28","doi-asserted-by":"publisher","unstructured":"Han, R., Wang, Y. & Lu, L. Sensitizing the efficiency of ICIs by neoantigen mRNA vaccines for HCC Ttreatment. Pharmaceutics 16, https:\/\/doi.org\/10.3390\/pharmaceutics16010059 (2023).","DOI":"10.3390\/pharmaceutics16010059"},{"key":"9891_CR29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/14728222.2024.2416975","volume":"28","author":"A Couzinet","year":"2024","unstructured":"Couzinet, A., Suzuki, T. & Nakatsura, T. Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy. Expert Opin. Ther. Targets 28, 895\u2013909 (2024).","journal-title":"Expert Opin. Ther. Targets"},{"key":"9891_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","volume":"125","author":"M Capurro","year":"2003","unstructured":"Capurro, M. et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125, 89\u201397 (2003).","journal-title":"Gastroenterology"},{"key":"9891_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1172\/JCI200113712","volume":"108","author":"J Filmus","year":"2001","unstructured":"Filmus, J. & Selleck, S. B. Glypicans: proteoglycans with a surprise. J. Clin. Investig. 108, 497\u2013501 (2001).","journal-title":"J. Clin. Investig."},{"key":"9891_CR32","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1158\/0008-5472.CAN-22-3895","volume":"83","author":"EJ Schepers","year":"2023","unstructured":"Schepers, E. J., Glaser, K., Zwolshen, H. M., Hartman, S. J. & Bondoc, A. J. Structural and functional impact of posttranslational modification of glypican-3 on liver carcinogenesis. Cancer Res. 83, 1933\u20131940 (2023).","journal-title":"Cancer Res."},{"key":"9891_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/med.21455","volume":"38","author":"F Zhou","year":"2018","unstructured":"Zhou, F., Shang, W., Yu, X. & Tian, J. Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med. Res. Rev. 38, 741\u2013767 (2018).","journal-title":"Med. Res. Rev."},{"key":"9891_CR34","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.2147\/IJN.S235058","volume":"15","author":"L Xia","year":"2020","unstructured":"Xia, L., Teng, Q., Chen, Q. & Zhang, F. Preparation and characterization of anti-GPC3 nanobody against hepatocellular carcinoma. Int J. Nanomed. 15, 2197\u20132205 (2020).","journal-title":"Int J. Nanomed."},{"key":"9891_CR35","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1053\/j.gastro.2020.02.011","volume":"158","author":"D Li","year":"2020","unstructured":"Li, D. et al. Persistent polyfunctional chimeric antigen receptor t cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in Mice. Gastroenterology 158, 2250\u20132265 e2220 (2020).","journal-title":"Gastroenterology"},{"key":"9891_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1053\/j.gastro.2015.05.055","volume":"149","author":"C Dargel","year":"2015","unstructured":"Dargel, C. et al. T cells engineered to express a T-cell receptor specific for glypican-3 to recognize and kill hepatoma cells in vitro and in Mice. Gastroenterology 149, 1042\u20131052 (2015).","journal-title":"Gastroenterology"},{"key":"9891_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang, R. H., Gao, W. & Zhang, L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat. Rev. Clin. Oncol. 20, 33\u201348 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9891_CR38","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1021\/acs.nanolett.8b03913","volume":"19","author":"L Rao","year":"2019","unstructured":"Rao, L. et al. A biomimetic nanodecoy traps zika virus to prevent viral infection and fetal microcephaly development. Nano Lett. 19, 2215\u20132222 (2019).","journal-title":"Nano Lett."},{"key":"9891_CR39","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1016\/j.biomaterials.2013.06.064","volume":"34","author":"H Li","year":"2013","unstructured":"Li, H. et al. Endoplasmic reticulum localization of poly(\u03c9-aminohexyl methacrylamide)s conjugated with (L-)-arginines in plasmid DNA delivery. Biomaterials 34, 7923\u20137938 (2013).","journal-title":"Biomaterials"},{"key":"9891_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","volume":"596","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109\u2013113 (2021).","journal-title":"Nature"},{"key":"9891_CR41","first-page":"1897","volume":"42","author":"M Zhang","year":"2022","unstructured":"Zhang, M. et al. Axillary lymphadenopathy in the COVID-19 era: what the radiologist needs to know. Radiogr Rev. Publ. Radiol. Soc. North Am. Inc. 42, 1897\u20131911 (2022).","journal-title":"Radiogr Rev. Publ. Radiol. Soc. North Am. Inc."},{"key":"9891_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang, R. et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat. Commun. 12, 832 (2021).","journal-title":"Nat. Commun."},{"key":"9891_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101686","volume":"5","author":"C Chen","year":"2024","unstructured":"Chen, C. et al. Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8(+) T cell exhaustion and anti-PD-1 resistance. Cell Rep. Med. 5, 101686 (2024).","journal-title":"Cell Rep. Med."},{"key":"9891_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","volume":"6","author":"Z Yan","year":"2025","unstructured":"Yan, Z., Wang, C., Wu, J., Wang, J. & Ma, T. TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives. Mol. Biomed. 6, 27 (2025).","journal-title":"Mol. Biomed."},{"key":"9891_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","volume":"35","author":"A Schietinger","year":"2014","unstructured":"Schietinger, A. & Greenberg, P. D. Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol. 35, 51\u201360 (2014).","journal-title":"Trends Immunol."},{"key":"9891_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23244-3","volume":"12","author":"J Koerner","year":"2021","unstructured":"Koerner, J. et al. PLGA-particle vaccine carrying TLR3\/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy. Nat. Commun. 12, 2935 (2021).","journal-title":"Nat. Commun."},{"key":"9891_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-immunol-032414-112116","volume":"33","author":"SE Bettigole","year":"2015","unstructured":"Bettigole, S. E. & Glimcher, L. H. Endoplasmic reticulum stress in immunity. Annu. Rev. Immunol. 33, 107\u2013138 (2015).","journal-title":"Annu. Rev. Immunol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09891-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09891-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09891-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:51:00Z","timestamp":1778626260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09891-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9891"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09891-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"644"}}